Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-004585

Options or other derivatives

  • Chief Scientific Officer acquired 53,590 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Georgantas Robert William III · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-02-08 Grant or award : show line 1 in the form Restricted Stock Units +31,537 31,537 31,537 D
2022-02-08 Grant or award : show line 2 in the form Restricted Stock Units +22,053 22,053 22,053 D
Loading xslF345X03/form4.xml…